Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Mr. Thomas P. Hess CPA, MBA

President & Chief Financial Officer

Mr. Keith E. Murphy

Company Secretary & Executive Chairman

Nazwa	Tytuł
Mr. Thomas P. Hess CPA, MBA	President & Chief Financial Officer
Mr. Keith E. Murphy	Company Secretary & Executive Chairman
Dr. Curtis M. Tyree Ph.D.	Senior Vice President of Strategy & Business Development
Ms. Vaidehi Joshi	Director of Discovery Biology & Director

Organovo Holdings, Inc.

Organovo Holdings, Inc. Struktura zarządzania

Informacje o kierownictwie